SCHEMBL24671545

SCHEMBL24671545

CC(=O)N1CCN(C[C@@H]2CCN(C(C)C)C2)CC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.47
CCR2 P41597 3/20 0.47
PIK3CD O00329 1/20 0.47
CNR1 P21554 1/20 0.41
HRH3 Q9Y5N1 4/20 0.40
TDP1 Q9NUW8 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CACNA2D1 P54289 1/20 0.38
CACNA1B Q00975 1/20 0.38
CACNB1 Q02641 1/20 0.38
CACNA1C Q13936 1/20 0.38
CYP1A2 P05177 1/20 0.35
CXCR3 P49682 1/20 0.35
CYP2D6 P10635 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
HTR3A P46098 1/20 0.34
HTR4 Q13639 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25603936 0.87 KCNH2 (0.47) KCNH2CCR2HRH3TDP1KDM4E
SCHEMBL25603933 0.87 KCNH2 (0.47) KCNH2CCR2HRH3TDP1KDM4E
SCHEMBL18705111 0.84 HRH3 (0.48) KCNH2CCR2PIK3CDHRH3TDP1
SCHEMBL26445295 0.82 KCNH2 (0.40) KCNH2CCR2HRH3TDP1KDM4E
SCHEMBL14453910 0.82 KCNH2 (0.40) KCNH2CCR2HRH3TDP1KDM4E
SCHEMBL23594008 0.82 KCNH2 (0.40) KCNH2CCR2HRH3TDP1KDM4E
SCHEMBL19083203 0.82 KCNH2 (0.40) KCNH2CCR2HRH3TDP1KDM4E
SCHEMBL25565194 0.80 PIK3CD (0.43) KCNH2CCR2PIK3CDHRH3TDP1
SCHEMBL25558603 0.79 HRH3 (0.41) KCNH2CCR2PIK3CDCNR1HRH3
SCHEMBL25461036 0.79 HRH3 (0.40) KCNH2CCR2HRH3ALDH1A1CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed